We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

I Understand

genOway Chosen by Tufts University for Major Framework Contract

News Dec 28, 2009

Read Time:

genOway reports an important framework agreement with the Tufts University (Boston, USA).

Following an international competition, the company has been selected for a framework contract for a two years renewable period.

Under the terms of the agreement, researchers at the Tufts University, whose prestigious areas of study cover oncology, cardiovascular disease and virology (especially AIDS), will benefit from the expertise gained by genOway in transgenic technologies and technological innovations developed by the company, such as inducible systems that secure and accelerate the development of sophisticated genetically modified mouse and rat models.

The financial terms of the agreement were not disclosed.

Deep Learning Algorithm Mines the Genome for Therapeutic Targets

News

A team of researchers have developed an algorithm through machine learning that helps predict sites of DNA methylation – a process that can change the activity of DNA without changing its overall structure – and could identify disease-causing mechanisms that would otherwise be missed by conventional screening methods.